TargetBreast cancer type 1 susceptibility protein(Homo sapiens (Human))
University Of Nebraska Medical Center
Curated by ChEMBL
University Of Nebraska Medical Center
Curated by ChEMBL
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of BRCA1 by fluorescence polarization assayMore data for this Ligand-Target Pair
TargetBreast cancer type 1 susceptibility protein(Homo sapiens (Human))
University Of Nebraska Medical Center
Curated by ChEMBL
University Of Nebraska Medical Center
Curated by ChEMBL
Affinity DataIC50: 1.60E+3nMAssay Description:Inhibition of BRCA1 by fluorescence polarization assayMore data for this Ligand-Target Pair
TargetBreast cancer type 1 susceptibility protein(Homo sapiens (Human))
University Of Nebraska Medical Center
Curated by ChEMBL
University Of Nebraska Medical Center
Curated by ChEMBL
Affinity DataIC50: 3.20E+3nMAssay Description:Inhibition of BRCA1 by fluorescence polarization assayMore data for this Ligand-Target Pair
TargetBreast cancer type 1 susceptibility protein(Homo sapiens (Human))
University Of Nebraska Medical Center
Curated by ChEMBL
University Of Nebraska Medical Center
Curated by ChEMBL
Affinity DataIC50: 4.60E+3nMAssay Description:Inhibition of BRCA1 by fluorescence polarization assayMore data for this Ligand-Target Pair
TargetBreast cancer type 1 susceptibility protein(Homo sapiens (Human))
University Of Nebraska Medical Center
Curated by ChEMBL
University Of Nebraska Medical Center
Curated by ChEMBL
Affinity DataIC50: 7.10E+3nMAssay Description:Inhibition of BRCA1 by fluorescence polarization assayMore data for this Ligand-Target Pair
TargetBreast cancer type 1 susceptibility protein(Homo sapiens (Human))
University Of Nebraska Medical Center
Curated by ChEMBL
University Of Nebraska Medical Center
Curated by ChEMBL
Affinity DataIC50: 1.08E+4nMAssay Description:Inhibition of BRCA1 by fluorescence polarization assayMore data for this Ligand-Target Pair
TargetBreast cancer type 1 susceptibility protein(Homo sapiens (Human))
University Of Nebraska Medical Center
Curated by ChEMBL
University Of Nebraska Medical Center
Curated by ChEMBL
Affinity DataIC50: 1.49E+4nMAssay Description:Inhibition of BRCA1 by fluorescence polarization assayMore data for this Ligand-Target Pair
TargetBreast cancer type 1 susceptibility protein(Homo sapiens (Human))
University Of Nebraska Medical Center
Curated by ChEMBL
University Of Nebraska Medical Center
Curated by ChEMBL
Affinity DataIC50: 1.50E+4nMAssay Description:Inhibition of BRCA1 by fluorescence polarization assayMore data for this Ligand-Target Pair
TargetBreast cancer type 1 susceptibility protein(Homo sapiens (Human))
University Of Nebraska Medical Center
Curated by ChEMBL
University Of Nebraska Medical Center
Curated by ChEMBL
Affinity DataIC50: 1.77E+4nMAssay Description:Inhibition of BRCA1 by fluorescence polarization assayMore data for this Ligand-Target Pair
TargetBreast cancer type 1 susceptibility protein(Homo sapiens (Human))
University Of Nebraska Medical Center
Curated by ChEMBL
University Of Nebraska Medical Center
Curated by ChEMBL
Affinity DataIC50: 1.84E+4nMAssay Description:Inhibition of BRCA1 by fluorescence polarization assayMore data for this Ligand-Target Pair
TargetBreast cancer type 1 susceptibility protein(Homo sapiens (Human))
University Of Nebraska Medical Center
Curated by ChEMBL
University Of Nebraska Medical Center
Curated by ChEMBL
Affinity DataIC50: 3.01E+4nMAssay Description:Inhibition of BRCA1 by fluorescence polarization assayMore data for this Ligand-Target Pair
TargetBreast cancer type 1 susceptibility protein(Homo sapiens (Human))
University Of Nebraska Medical Center
Curated by ChEMBL
University Of Nebraska Medical Center
Curated by ChEMBL
Affinity DataIC50: 3.50E+4nMAssay Description:Inhibition of BRCA1 by fluorescence polarization assayMore data for this Ligand-Target Pair
TargetBreast cancer type 1 susceptibility protein(Homo sapiens (Human))
University Of Nebraska Medical Center
Curated by ChEMBL
University Of Nebraska Medical Center
Curated by ChEMBL
Affinity DataIC50: 5.28E+4nMAssay Description:Inhibition of BRCA1 by fluorescence polarization assayMore data for this Ligand-Target Pair
TargetBreast cancer type 1 susceptibility protein(Homo sapiens (Human))
University Of Nebraska Medical Center
Curated by ChEMBL
University Of Nebraska Medical Center
Curated by ChEMBL
Affinity DataIC50: 9.84E+4nMAssay Description:Inhibition of BRCA1 by fluorescence polarization assayMore data for this Ligand-Target Pair
TargetBreast cancer type 1 susceptibility protein(Homo sapiens (Human))
University Of Nebraska Medical Center
Curated by ChEMBL
University Of Nebraska Medical Center
Curated by ChEMBL
Affinity DataIC50: 1.72E+5nMAssay Description:Inhibition of BRCA1 by fluorescence polarization assayMore data for this Ligand-Target Pair
TargetBreast cancer type 1 susceptibility protein(Homo sapiens (Human))
University Of Nebraska Medical Center
Curated by ChEMBL
University Of Nebraska Medical Center
Curated by ChEMBL
Affinity DataIC50: >2.50E+5nMAssay Description:Inhibition of BRCA1 by fluorescence polarization assayMore data for this Ligand-Target Pair
TargetBreast cancer type 1 susceptibility protein(Homo sapiens (Human))
University Of Nebraska Medical Center
Curated by ChEMBL
University Of Nebraska Medical Center
Curated by ChEMBL
Affinity DataIC50: >2.50E+5nMAssay Description:Inhibition of BRCA1 by fluorescence polarization assayMore data for this Ligand-Target Pair
TargetBreast cancer type 1 susceptibility protein(Homo sapiens (Human))
University Of Nebraska Medical Center
Curated by ChEMBL
University Of Nebraska Medical Center
Curated by ChEMBL
Affinity DataIC50: >2.50E+5nMAssay Description:Inhibition of BRCA1 by fluorescence polarization assayMore data for this Ligand-Target Pair
TargetBreast cancer type 1 susceptibility protein(Homo sapiens (Human))
University Of Nebraska Medical Center
Curated by ChEMBL
University Of Nebraska Medical Center
Curated by ChEMBL
Affinity DataIC50: >2.50E+5nMAssay Description:Inhibition of BRCA1 by fluorescence polarization assayMore data for this Ligand-Target Pair